This presentation will focus on the shift towards hydrogen as a carrier gas in Gas Chromatography-Mass Spectrometry (GC-MS), motivated by helium's scarcity and high cost. It will discuss the benefits of hydrogen and address challenges like safety and the impact on analytical accuracy.

Cell-to-cell communication in cancer is pivotal for tumor progression, metastasis, and treatment resistance. This complex network of signalling pathways allows cancer cells to interact, shaping their behavior and response to therapy.

Biotherapeutic drugs are complex and can perform their function through interactions with more than one target molecule. During development and quality control, a range of analytical technologies are used to characterize biotherapeutic drugs in terms of their structural integrity and activity. Ligand-binding assays are relevant for characterization and quantitation of the functional drug, however current analytical approaches may no longer be sufficient for analysis of emerging drug modalities.
Biacore™ assays are based on ligand binding and used in development and characterization of drug product using active concentration measurements, target binding, potency (E50)
and Fc receptor (FcR) analysis.

This webinar explores a highly sensitive, automated assay workflow to provide high-quality results for low-abundance biomarkers in serum, plasma and cerebrospinal fluid.

This webinar explores how a next-generation automated ELISA technique can profile the dysregulated host response to COVID-19 in association with viral load in plasma.

This webinar will review how kinetic characterization of biological interactions can guide the selection of best-in-class detector molecules to enhance lateral flow diagnostics and outline the benefits of characterizing and selecting your lateral flow antibodies using SPR technology.